Rossios, ChristosBashir, TufailAdamson, SimonAdamson, SimonAkpan, AsangaedemAspray, Terry J.Avenell, AlisonBand, Margaret MBurton, Louise ACvoro, VeraDonnan, Peter T.Duncan, Gordon WGeorge, JacobGordon, Adam LGregson, Celia LHapca, AdrianHume, Cheryl LJackson, Thomas A.Kerr, SimonKilgour, Alixe H. M.Masud, TahirMcKenzie, AndrewMcKenzie, EmmaPatel, HarnishPilvinyte, KristinaRoberts, Helen C.Sayer, Avan AihieSmith, Karen TSoiza, RoySteves, Claire J.Struthers, Allan DTiwari, DivyaWhitney, JulieWitham, Miles DKemp, Paul R2024-02-122024-02-122023-10-20Rossios, C, Bashir, T, Adamson, S, Adamson, S, Akpan, A, Aspray, T J, Avenell, A, Band, M M, Burton, L A, Cvoro, V, Donnan, P T, Duncan, G W, George, J, Gordon, A L, Gregson, C L, Hapca, A, Hume, C L, Jackson, T A, Kerr, S, Kilgour, A H M, Masud, T, McKenzie, A, McKenzie, E, Patel, H, Pilvinyte, K, Roberts, H C, Sayer, A A, Smith, K T, Soiza, R, Steves, C J, Struthers, A D, Tiwari, D, Whitney, J, Witham, M D & Kemp, P R 2023, 'ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia : Results from the LACE trial', PloS ONE, vol. 18, no. 10, e0292402. https://doi.org/10.1371/journal.pone.02924021932-6203ORCID: /0000-0002-1397-4272/work/148047371ORCID: /0000-0003-4813-5628/work/167120336https://hdl.handle.net/2164/22749Funding The LACE trial (project reference 13/53/03) is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership. Acknowledgements The authors would also thank the efforts of all the research nurses and other site research staff who recruited participants to the trial, all the participants, and all the staff of the Tayside Clinical Trials Unit for their support of the trial171002044engR MedicineMedical Research Council (MRC)13/53/03National Institute for Health Research (NIHR)Supplementary DataSupplementary InformationRJournal article10.1371/journal.pone.02924021810